Chemed Corporation (CHE)
NYSE: CHE · Real-Time Price · USD
457.29
+3.57 (0.79%)
At close: Jul 16, 2025, 4:00 PM
457.73
+0.44 (0.10%)
After-hours: Jul 16, 2025, 4:52 PM EDT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
VITAS | 1.53B | Log In | Log In | Log In | Log In | Upgrade |
VITAS Growth | 16.62% | Log In | Log In | Log In | Log In | Upgrade |
Roto-Rooter | 900.31M | Log In | Log In | Log In | Log In | Upgrade |
Roto-Rooter Growth | -3.24% | Log In | Log In | Log In | Log In | Upgrade |
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
VITAS Income From Operations | 263.97M | Log In | Log In | Log In | Log In | Upgrade |
VITAS Income From Operations Growth | 31.09% | Log In | Log In | Log In | Log In | Upgrade |
Roto-Rooter Income From Operations | 194.52M | Log In | Log In | Log In | Log In | Upgrade |
Roto-Rooter Income From Operations Growth | -10.92% | Log In | Log In | Log In | Log In | Upgrade |
Corporate Income From Operations | -91.99M | Log In | Log In | Log In | Log In | Upgrade |
Corporate Income From Operations Growth | -8.91% | Log In | Log In | Log In | Log In | Upgrade |
Other | 5.78M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
EBITDA by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
VITAS Adjusted EBITDA | 285.54M | Log In | Log In | Log In | Log In | Upgrade |
VITAS Adjusted EBITDA Growth | 28.82% | Log In | Log In | Log In | Log In | Upgrade |
Roto-Rooter Adjusted EBITDA | 237.09M | Log In | Log In | Log In | Log In | Upgrade |
Roto-Rooter Adjusted EBITDA Growth | -8.81% | Log In | Log In | Log In | Log In | Upgrade |
Corporate Adjusted EBITDA | -19.62M | Log In | Log In | Log In | Log In | Upgrade |
Corporate Adjusted EBITDA Growth | -1.75% | Log In | Log In | Log In | Log In | Upgrade |
Net Income by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
VITAS Net Income | 216.82M | Log In | Log In | Log In | Log In | Upgrade |
VITAS Net Income Growth | 13.78% | Log In | Log In | Log In | Log In | Upgrade |
Roto-Rooter Net Income | 160.05M | Log In | Log In | Log In | Log In | Upgrade |
Roto-Rooter Net Income Growth | -2.23% | Log In | Log In | Log In | Log In | Upgrade |
Corporate Net Income | -74.87M | Log In | Log In | Log In | Log In | Upgrade |
Corporate Net Income Growth | -8.02% | Log In | Log In | Log In | Log In | Upgrade |
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Total Average Daily Census (ADC) (Days) | 21.17K | Log In | Log In | Log In | Log In | Upgrade |
Total Average Daily Census (ADC) (Days) Growth | 13.11% | Log In | Log In | Log In | Log In | Upgrade |
Total Admissions | 67.45K | Log In | Log In | Log In | Log In | Upgrade |
Total Admissions Growth | 7.26% | Log In | Log In | Log In | Log In | Upgrade |
Total Discharges | 64.62K | Log In | Log In | Log In | Log In | Upgrade |
Total Discharges Growth | 10.54% | Log In | Log In | Log In | Log In | Upgrade |
Average Length of Stay (Days) | 103.00 | Log In | Log In | Log In | Log In | Upgrade |
Average Length of Stay (Days) Growth | 14.24% | Log In | Log In | Log In | Log In | Upgrade |
Median Length of Stay (Days) | 17.00 | Log In | Log In | Log In | Log In | Upgrade |
Median Length of Stay (Days) Growth | 0% | Log In | Log In | Log In | Log In | Upgrade |